Skip to main content
CRS 2025 Annual Meeting & Exposition Main banner
Rate Poster

Artificial Intelligence and Predictive Models

(108) Novel Integrated PBPK-IVIVC Framework for Predicting Human PK of Sustained-Release Formulations

Introduction:

This study aimed to develop an innovative modeling framework that seamlessly integrates physiologically-based pharmacokinetic (PBPK) principles with in vitro-in vivo correlation (IVIVC) methodology to predict human pharmacokinetics of sustained-release formulations, using ruxolitinib as a model compound.

Learning Objectives:

  • Upon completion, participants will be able to explain how PBPK-IVIVC models predict human PK.